Trial Profile
Influence of mycophenolate mofetil (Cellcept) on the progression of diabetic nephropathy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2016
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 09 Dec 2016 Status changed from recruiting to completed.
- 29 Jul 2011 New trial record